In support, most studies so far showed that IMIDs treated with inhibitors of pro-inflammatory cytokines have no evidence for a more severe course of Covid-19 and with some treatments, e.g., TNF inhibitors, an even milder case of COVID-19 has been observed [16–18]. The gene discussed is TNF; the disease is COVID-19.